目的 分析2011—2013年贵港市人民医院抗肿瘤药物的使用情况和用药趋势。方法 通过回顾性检索贵港市人民医院HIS系统2011—2013年的数据，并对各类抗肿瘤药物的销售金额、销售量及构成比等进行统计。结果 2011—2013年抗肿瘤药物的销售金额逐年增大，尤其抗代谢药和植物来源抗肿瘤药及其衍生物的增长幅度较大，烷化剂类药物的销售金额却呈下降趋势。销售金额前3位的抗肿瘤药分别是吉西他滨、多西他赛、培美曲塞。销量最大的抗肿瘤药是氟尿嘧啶，其次是吉西他滨。结论 贵港市人民医院抗肿瘤药物的销售金额增长率接近全国水平，抗代谢药和植物来源抗肿瘤药及其衍生物的市场需求大，应加大对其品种的生产和优化力度。

Objective To analyze the usage of anticancer drugs in Guigang City People's Hospital from 2011 to 2013. Methods The data were drawn from the HIS system in the hospital retrospectively, and the consumption sum, sales volume, and component ratio of anticancer drugs were analyzed. Results Consumption sum of anticancer drugs increased year by year substantially during 2011－2013, especially antimetabolite and anticancer drugs from plants and their derivatives, but alkylating drugs showed a downward trend in demand. Consumption sum of top three drugs in anticancer drugs were gemcitabine, docetaxel, and pemetrexed. The largest sale of the anticancer drugs was fluorouracil, then was gemcitabine. Conclusion The growth rate of sales of anticancer drugs in Guigang City People's Hospital closes to the national level. The antimetabolite and anticancer drugs from plants and their derivatives have a big demand in the market, therefore the varieties of production and optimization should be intensified.